A recent study has demonstrated that primary T-cells transduced with a multispecific CAR (targeting the CD4-binding site gp120 and the co-receptor gp120 binding site) can potently inhibit cellular HIV infection by up to 99% in vitro and >97% in vivo (17, 202). This evidence concerns the gene ITIH4 and HIV infectious disease.